MM-451 Treatment Patterns Among Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Receiving Second-and Third-Line Therapy in a Medicare Population
- 20 September 2022
- journal article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 22, S423